Home›Stocks›MAZE

MAZE — structural market context

Maze Therapeutics, Inc. Common

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

MAZE short interest & days to cover

SHARES SHORT
5.7M
% OF FLOAT
—
DAYS TO COVER
10.4
CHANGE VS PRIOR
-4.1%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-15 (22d ago)

MAZE fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-02 · 35d1K$26.53
2026-09-01 · 36d2K$26.57
2026-08-28 · 40d4K$28.6

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

MAZE insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 26 sales

InsiderTypeSharesValueFiled
Bernstein Harold · officer: President, R&D & CMOSell (S)16K$435K2026-10-02
Coloma Jason V · director, officer: Chief Executive OfficerSell (S)32K$862K2026-10-02
Coloma Jason V · director, officer: Chief Executive OfficerSell (S)3K$70K2026-10-02
Dandekar Atul · officer: CSBOSell (S)8K$203K2026-10-01
Bernstein Harold · officer: President, R&D & CMOSell (S)10K$255K2026-09-08

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

MAZE analyst ratings — with each firm's recent 5-session hit rate

FirmActionRatingFirm 5-session hit rate* (2026-09-23 – 2026-10-07)Published
CitigroupinitialiseBuy45.3% (n=64)2026-09-23

*Rating actions from public feeds. Where shown, the firm's hit rate is the share of its calls whose raw close-to-close return over the next 5 trading sessions moved in the call's direction, with no benchmark, over rating actions published between 2026-09-23 and 2026-10-07 (firms with >=30 graded calls). It describes those past calls; it does not grade this one.

Frequently asked questions

Are insiders buying MAZE?
In the last 12 months of SEC Form 4 filings, MAZE recorded 0 open-market insider purchases and 26 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about MAZE?
The most recent action: Citigroup initialise to Buy on 2026-09-23. Across 64 of Citigroup's graded calls published 2026-09-23 to 2026-10-07, 45.3% saw the stock's raw 5-session return move in the call's direction (no benchmark). We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.
Is this page telling me to buy or sell MAZE?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with M

MUR · Murphy Oil Corp.MAMA · Mama's Creations, Inc. CommonMASS · 908 Devices Inc.MIAX · Miami International Holdings,MIST · Milestone Pharmaceuticals Inc.MNGPF · Man Group PLCAll M →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.